)
)
Sprint Bioscience Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Sprint Bioscience
Access all reports
Sprint Bioscience AB is a Swedish biotechnology company focused on developing innovative cancer therapies. It specializes in drug discovery for oncology, leveraging a fragment-based drug discovery (FBDD) platform to accelerate the identification of promising molecules for cancer treatment. The company's research pipeline includes drug candidates targeting cancer metabolism and autophagy, with the aim of enhancing therapeutic approaches for hard-to-treat cancers. It is headquartered in Huddinge, Sweden, and its shares are listed on the Stockholm Stock Exchange.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
SPRINT
Country
🇸🇪 Sweden